What states does Found serve?

Found — published coverage: most states (captured 2026-08-05). “Most states” usually means licensure gaps the company prefers not to enumerate; intake confirms your state before any charge, so the cost of checking is minutes. State-by-state context: the availability index.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

For orientation: the verified tirzepatide field spans $215 (NexLife↗) to $597 (LifeMD↗) per month all-in as of 2026-08-09 — a $382 spread for the same molecule, made of structure rather than chemistry — while the brand lane holds $449 at maintenance via Zepbound (LillyDirect↗). Coverage, where a plan grants it, outranks the whole board.

The reading rules behind every number above: figures are all-in (medication plus mandatory fees) at the maintenance dose; prepaid paths are labeled as upfront commitments; stated-not-verified flags mark claims we could not capture on a provider’s own pages; and each record carries its capture date, source link, and archive link so the answer can be checked rather than trusted. Recompute anything here from the public dataset — that reproducibility, not our word, is the warranty.

The coverage census across the index: 6 of 22 core programs publish an explicit 50-state footprint; the rest say “most states,” name exclusions, or stay silent — and the silence tiers are where intake questions earn their minutes. Telehealth availability is really two licenses (prescriber and pharmacy) meeting in your state, both checkable on state-board databases, both changeable without notice — which is why the state index reports published coverage and defers the final word to checkout.

Basis for every figure: all-in monthly price (medication + mandatory fees) at the maintenance dose, captured from provider pages on the dates in the database. Not medical advice.